Curanex Pharmaceuticals Inc (CURX) vs Imunon, Inc. (IMNN)

Curanex Pharmaceuticals Inc and Imunon, Inc. are both Biotechnology companies. Curanex Pharmaceuticals Inc and Imunon, Inc. are of similar size ($7.3M and $7.0M). Across the 10 metrics below, Curanex Pharmaceuticals Inc leads on 6 and Imunon, Inc. on 4.

Valuation

Metric CURX IMNN Biotechnology median
P/E n/m n/m 7.88
P/S n/m 14.76 11.47
P/B 1.40 3.81 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 12.10 10.73
Earnings yield (164.56%) (271.63%) (28.84%)
Free cash flow yield (179.68%) (206.00%) (23.03%)

Profitability

Metric CURX IMNN Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (411.10%) (641.02%) (57.72%)
Return on assets (357.22%) (123.93%) (49.22%)
Return on invested capital (356.67%) (324.37%) 0.00%

Growth

Metric CURX IMNN Biotechnology median
Revenue growth (TTM) — 0.00% 5.64%
EPS growth (last fiscal year) (466.67%) 67.66% —
Revenue growth, 5-year CAGR — 0.00% 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CURX IMNN Biotechnology median
Debt to equity 0.00 1.32 0.00
Current ratio 45.95 1.82 4.73
Net debt to EBITDA 1.20 0.63 0.96

Dividend

Metric CURX IMNN Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric CURX IMNN Biotechnology median
Market cap 6.98m 7.30m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack